ICCC
ImmuCell CorporationNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$59.71M
P/E Ratio
—
EPS
$-0.12
Beta
0.31
52W High
$7.60
52W Low
$4.52
50-Day MA
$6.39
200-Day MA
$6.23
Dividend Yield
—
Profit Margin
-3.76%
Forward P/E
—
PEG Ratio
0.00
About ImmuCell Corporation
ImmuCell Corporation, an animal health company, develops, manufactures and markets products that improve the health and productivity of dairy and beef cattle in the United States and internationally. The company is headquartered in Portland, Maine.
Fundamentals
| Revenue (TTM) | $27.64M |
| Gross Profit (TTM) | $11.45M |
| EBITDA | $5.18M |
| Operating Margin | 9.73% |
| Return on Equity | -3.81% |
| Return on Assets | 3.49% |
| Revenue/Share (TTM) | $3.06 |
| Book Value | $2.99 |
| Price-to-Book | 2.13 |
| Price-to-Sales (TTM) | 2.16 |
| EV/Revenue | 2.424 |
| EV/EBITDA | 31.31 |
| Quarterly Earnings Growth (YoY) | -63.40% |
| Quarterly Revenue Growth (YoY) | -1.60% |
| Shares Outstanding | $9.05M |
| Float | $6.02M |
| % Insiders | 32.10% |
| % Institutions | 20.39% |
Data last updated: 4/8/2026